ArticleClinical drug investigation2021

Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy.

Pietro Ferrara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.